VCIM
IMGN

Velan Capital Investment Management’s Immunogen Inc IMGN Stock Holding History

Velan Capital Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-189,500
Closed -$5.62M – 27
2023
Q4 		$5.62M Hold
189,500
– – 3.28% 8
2023
Q3 		$3.01M Hold
189,500
– – 2.43% 12
2023
Q2 		$3.58M Buy
+189,500
New +$2.24M 3.32% 11

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Velan Capital Investment Management's IMGN Position: Q1 2024 in Review

Velan Capital Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 189,500 shares — an estimated $5.62M sold.

Velan Capital Investment Management first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $5.62M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Velan Capital Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Velan Capital Investment Management sold 189,500 Immunogen Inc shares in Q1 2024, an estimated $5.62M.
  • Velan Capital Investment Management first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Velan Capital Investment Management's Immunogen Inc position peaked at $5.62M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Velan Capital Investment Management's 13F filing for Q1 2024, filed 14 May 2024.